Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 607


National, State, and Selected Local Area Vaccination Coverage Among Children Aged 19-35 Months - United States, 2014.

Hill HA, Elam-Evans LD, Yankey D, Singleton JA, Kolasa M.

MMWR Morb Mortal Wkly Rep. 2015 Aug 28;64(33):889-96.


A longitudinal cohort study of the relationship between Thimerosal-containing hepatitis B vaccination and specific delays in development in the United States: Assessment of attributable risk and lifetime care costs.

Geier DA, Kern JK, Hooker BS, King PG, Sykes LK, Geier MR.

J Epidemiol Glob Health. 2015 Jul 9. pii: S2210-6006(15)00064-7. doi: 10.1016/j.jegh.2015.06.002. [Epub ahead of print]


Effectiveness of prevention of mother-to-child transmission practice in three provinces of Southern China.

Wang F, Zheng H, Zhang G, Ding Z, Li F, Zhong G, Chen Y, Jia Y, Miao N, Wu Z, Sun X, Li L, Liang X, Cui F.

Hum Vaccin Immunother. 2015;11(8):2061-7. doi: 10.1080/21645515.2015.1023972.


[Clinical observation of telbivudine's antiviral efficacy and protection against mother-to-infant transmission of chronic hepatitis B during the first trimester of pregnancy].

Chen C, Tu X, Cheng Q, Chen F, Dai Y, Gong F, Lin X.

Zhonghua Gan Zang Bing Za Zhi. 2015 Jan;23(1):9-12. doi: 10.3760/cma.j.issn.1007-3418.2015.01.004. Chinese.


Tenofovir rescue therapy in pregnant females with chronic hepatitis B.

Hu YH, Liu M, Yi W, Cao YJ, Cai HD.

World J Gastroenterol. 2015 Feb 28;21(8):2504-9. doi: 10.3748/wjg.v21.i8.2504.


Hepatitis B surface antigen seroprevalence among children in Papua New Guinea, 2012-2013.

Kitau R, Datta SS, Patel MK, Hennessey K, Wannemuehler K, Sui G, Lagani W.

Am J Trop Med Hyg. 2015 Mar;92(3):501-6. doi: 10.4269/ajtmh.14-0537. Epub 2015 Jan 12.


Mouse models for therapeutic vaccination against hepatitis B virus.

Dembek C, Protzer U.

Med Microbiol Immunol. 2015 Feb;204(1):95-102. doi: 10.1007/s00430-014-0378-6. Epub 2014 Dec 19. Review.


Applicability and efficacy of a model for prevention of perinatal transmission of hepatitis B virus infection: single center study in Egypt.

El-Karaksy HM, Mohsen LM, Saleh DA, Hamdy MS, Yassin NA, Farouk M, Salit ME, El-Shabrawi MH.

World J Gastroenterol. 2014 Dec 7;20(45):17075-83. doi: 10.3748/wjg.v20.i45.17075.


Population-based interventions to reduce the public health burden related with hepatitis B virus infection in the gambia, west Africa.

Shimakawa Y, Lemoine M, Mendy M, Njai HF, D'Alessandro U, Hall A, Thursz M, Njie R.

Trop Med Health. 2014 Jun;42(2 Suppl):59-64. doi: 10.2149/tmh.2014-S08.


Durability of antibody response against hepatitis B virus in healthcare workers vaccinated as adults.

Gara N, Abdalla A, Rivera E, Zhao X, Werner JM, Liang TJ, Hoofnagle JH, Rehermann B, Ghany MG.

Clin Infect Dis. 2015 Feb 15;60(4):505-13. doi: 10.1093/cid/ciu867. Epub 2014 Nov 10.


Hepatitis B infection among Nigerian children admitted to a children's emergency room.

Sadoh AE, Ofili A.

Afr Health Sci. 2014 Jun;14(2):377-83. doi: 10.4314/ahs.v14i2.13.


Effects of hepatitis B immunization on prevention of mother-to-infant transmission of hepatitis B virus and on the immune response of infants towards hepatitis B vaccine.

Zhang L, Gui XE, Teter C, Zhong H, Pang Z, Ding L, Li F, Zhou Y, Zhang L.

Vaccine. 2014 Oct 21;32(46):6091-7. doi: 10.1016/j.vaccine.2014.08.078. Epub 2014 Sep 18.


Preventing hepatitis B and hepatocellular carcinoma in South Africa: The case for a birth-dose vaccine.

Spearman CW, Sonderup MW.

S Afr Med J. 2014 Jul 25;104(9):610-2. doi: 10.7196/samj.8607.


A dose-response relationship between organic mercury exposure from thimerosal-containing vaccines and neurodevelopmental disorders.

Geier DA, Hooker BS, Kern JK, King PG, Sykes LK, Geier MR.

Int J Environ Res Public Health. 2014 Sep 5;11(9):9156-70. doi: 10.3390/ijerph110909156.


Vaccination of preterm infants by polyvalent vaccines: immunogenicity and safety- review of literature.

Czajka H, Lauterbach R, Pawlik D.

Dev Period Med. 2014 Jul-Sep;18(3):360-6. Review.


National, state, and selected local area vaccination coverage among children aged 19-35 months - United States, 2013.

Elam-Evans LD, Yankey D, Singleton JA, Kolasa M; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2014 Aug 29;63(34):741-8.


Hepatitis B virus in the Lao People's Democratic Republic: a cross sectional serosurvey in different cohorts.

Black AP, Nouanthong P, Nanthavong N, Souvannaso C, Vilivong K, Jutavijittum P, Samountry B, Lütteke N, Hübschen JM, Goossens S, Quet F, Buisson Y, Muller CP.

BMC Infect Dis. 2014 Aug 23;14:457. doi: 10.1186/1471-2334-14-457.


Hepatitis B virus: where do we stand and what is the next step for eradication?

Komatsu H.

World J Gastroenterol. 2014 Jul 21;20(27):8998-9016. doi: 10.3748/wjg.v20.i27.8998. Review.


Gateway to Care campaign: a public health initiative to reduce the burden of hepatitis B in Haimen City, China.

Chen G, Block JM, Evans AA, Huang P, Cohen C.

BMC Public Health. 2014 Jul 27;14:754. doi: 10.1186/1471-2458-14-754.


Hepatitis B virus antibody levels 7 to 9 years after booster vaccination in Alaska native persons.

Keck JW, Bulkow LR, Raczniak GA, Negus SE, Zanis CL, Bruce MG, Spradling PR, Teshale EH, McMahon BJ.

Clin Vaccine Immunol. 2014 Sep;21(9):1339-42. doi: 10.1128/CVI.00263-14. Epub 2014 Jul 23.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk